Cargando…

Immune Monitoring After Allogeneic Hematopoietic Cell Transplantation: Toward Practical Guidelines and Standardization

Hematopoietic cell transplantation (HCT) is often a last resort, but potentially curative treatment option for children suffering from hematological malignancies and a variety of non-malignant disorders, such as bone marrow failure, inborn metabolic disease or immune deficiencies. Although efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boelens, Jaap Jan, Hosszu, Kinga K., Nierkens, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472532/ https://www.ncbi.nlm.nih.gov/pubmed/32974239 http://dx.doi.org/10.3389/fped.2020.00454

Ejemplares similares

Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?
por: Plantinga, Maud, et al.
Publicado: (2014)

Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism
por: Tan, Emily Y., et al.
Publicado: (2019)

Population pharmacokinetics of clofarabine for allogeneic hematopoietic cell transplantation in paediatric patients
por: Nijstad, A. Laura, et al.
Publicado: (2021)

Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation
por: Teshima, Takanori, et al.
Publicado: (2023)

Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions
por: Yanir, Asaf, et al.
Publicado: (2022)

Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
por: Langenhorst, Jurgen B., et al.
Publicado: (2018)

Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Immune Dysregulatory Disorders
por: Bakhtiar, Shahrzad, et al.
Publicado: (2019)

Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation
por: Langenhorst, Jurgen B., et al.
Publicado: (2020)

Morbidity and Mortality Associated With Respiratory Virus Infections in Allogeneic Hematopoietic Cell Transplant: Too Little Defense or Harmful Immunity?
por: Versluys, Anne Birgitta, et al.
Publicado: (2018)

Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
por: Dekker, Linde, et al.
Publicado: (2020)

Case Report: Immune Dysregulation Due to Toxoplasma gondii Reactivation After Allogeneic Hematopoietic Cell Transplant
por: Lindell, Robert B., et al.
Publicado: (2021)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
por: Qu, Yuhua, et al.
Publicado: (2022)

Neurological complications following pediatric allogeneic hematopoietic stem cell transplantation: Risk factors and outcome
por: Zaidman, Irina, et al.
Publicado: (2022)

A Guidance for Concomitant Drug Reconciliation Prior to Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults
por: Apsel Winger, Beth, et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy
por: Truong, Tony H., et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept
por: Meesters-Ensing, J.I., et al.
Publicado: (2022)

Phenotypes and Baseline Risk Factors of Acute Kidney Injury in Children After Allogeneic Hematopoietic Stem Cell Transplantation
por: Daraskevicius, Justinas, et al.
Publicado: (2020)

Avatrombopag for the treatment of thrombocytopenia in children's patients following allogeneic hematopoietic stem-cell transplantation: A pilot study
por: Ruan, Yongsheng, et al.
Publicado: (2023)

High Diagnostic Yield of Dedicated Pulmonary Screening before Hematopoietic Cell Transplantation in Children
por: Versluys, Anne Birgitta, et al.
Publicado: (2015)

Long-term transplant outcomes after allogeneic hematopoietic transplant in pediatric patients with hematological malignancies are influenced by severe chronic graft vs. host disease and immune reconstitution
por: Molina, Blanca, et al.
Publicado: (2022)

The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation
por: Peci, Flavia, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for PEX1-Related Zellweger Spectrum Disorder: A Case Report and Literature Review
por: Chen, Kai, et al.
Publicado: (2021)

Splenic rupture and fungal endocarditis in a pediatric patient with invasive fusariosis after allogeneic hematopoietic stem cell transplantation for aplastic anemia: A case report
por: Hannemann, Maurice, et al.
Publicado: (2022)

The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders: A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT
por: Bakhtiar, Shahrzad, et al.
Publicado: (2019)

Case report: Application of nirmatrelvir/ritonavir to treat COVID-19 in a severe aplastic anemia child after allogeneic hematopoietic stem cell transplantation
por: Huang, Jinhua, et al.
Publicado: (2022)

Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management
por: Dvorak, Christopher C., et al.
Publicado: (2019)

Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation
por: Spel, Lotte, et al.
Publicado: (2013)

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
por: Kellner, Joshua N., et al.
Publicado: (2018)

Effects of Hematopoietic Cell Transplantation on the Pulmonary Immune Response to Infection
por: Zinter, Matt S., et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies
por: Gennery, Andrew R., et al.
Publicado: (2019)

Hematopoietic Cell Transplantation for Sickle Cell Disease
por: Krishnamurti, Lakshmanan
Publicado: (2021)

Case Report: Liver as a Source of Hematopoietic Stem Cells After Liver Transplantation Following Hematopoietic Stem Cell Transplantation
por: Jarmoliński, Tomasz, et al.
Publicado: (2022)

Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
por: Chiesa, Robert, et al.
Publicado: (2022)

Autoimmune Cytopenias in Pediatric Hematopoietic Cell Transplant Patients
por: Neely, Jessica A., et al.
Publicado: (2019)

Hematopoietic Stem Cell Transplant for the Treatment of X-MAID
por: Henrickson, Sarah E., et al.
Publicado: (2019)

Hematopoietic Cell Transplantation for MHC Class II Deficiency
por: Lum, Su Han, et al.
Publicado: (2019)

Editorial: Advances in Pediatric Hematopoietic Cell Therapies and Transplantation
por: Katsanis, Emmanuel, et al.
Publicado: (2022)

The perception of pediatric sickle cell anemia patient's caregivers toward hematopoietic stem cell transplantation (single-center experience, Saudi Arabia)
por: Monagel, Dania A., et al.
Publicado: (2023)

The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care
por: Saglio, Francesco, et al.
Publicado: (2014)

Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency
por: Gennery, Andrew R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_77iq6pn8tqm74tbfget760sq9i